Last reviewed · How we verify
Giving atropine at heart rates below 30 beats per minute — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Giving atropine at heart rates below 30 beats per minute (Giving atropine at heart rates below 30 beats per minute) — University of Hamburg-Eppendorf.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Giving atropine at heart rates below 30 beats per minute TARGET | Giving atropine at heart rates below 30 beats per minute | University of Hamburg-Eppendorf | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Giving atropine at heart rates below 30 beats per minute CI watch — RSS
- Giving atropine at heart rates below 30 beats per minute CI watch — Atom
- Giving atropine at heart rates below 30 beats per minute CI watch — JSON
- Giving atropine at heart rates below 30 beats per minute alone — RSS
Cite this brief
Drug Landscape (2026). Giving atropine at heart rates below 30 beats per minute — Competitive Intelligence Brief. https://druglandscape.com/ci/giving-atropine-at-heart-rates-below-30-beats-per-minute. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab